Methods, compounds, and compositions for delivering 1,3-propan ed isulfonic acid

Details for Australian Patent Application No. 2010282170 (hide)

Owner BELLUS Health Inc.

Inventors Kong, Xianqi; Levens, Nigel; Bouzide, Abderrahim; Ciblat, Stephane; Frenette, Richard; Renaud, Johanne

Agent Spruson & Ferguson

Pub. Number AU-A-2010282170

PCT Pub. Number WO2011/017800

Priority 61/232,597 10.08.09 US

Filing date 6 August 2010

Wipo publication date 17 February 2011

International Classifications

C07C 309/05 (2006.01) Sulfonic acids

A61K 31/185 (2006.01) - Acids

A61K 31/255 (2006.01)

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

C07C 303/26 (2006.01) Preparation of esters or amides of sulfuric acids

C07C 309/65 (2006.01) Sulfonic acids

Event Publications

1 March 2012 PCT application entered the National Phase

  PCT publication WO2011/017800 Priority application(s): WO2011/017800

28 June 2012 Assignment before Grant

  BELLUS Health Inc. The application has been assigned to BHI Limited Partnership 2011

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010282174-System, method, computer program for multidirectional pathway selection

2010282169-Vaccine having a peptide adjuvant for eliciting a specific immune response to treat viral infection and other conditions